Cognitive Neurology
Description
The Cognitive Neurology group investigates neurodegenerative disease and conducts research on the clinical features, causes, diagnosis, and treatments of these diseases.
The Cognitive Neurology group provides consulting services and has developed major research programs. We have established several treatment programs for Alzheimer's disease and have specialized expertise in Pick's disease and focal atrophies. Our research interests include the use of functional MRI to examine affect and behavioral changes in Frontotemporal Dementia, the genetics of dementia, use of MRI for early diagnosis of dementia, and the basic cell biology of neurodegenerative disease.
The group participates in multicenter academic and pharmaceutical company sponsored research. Examples of these include the NIH-sponsored Alzheimer's Disease Neuroimaging Initiative (ADNI), and the major clinical trials from Elan (Bapaneuzimab and Scyllo-insitol) and Myriad (Flurizan).
Our staff consists of two neuropsychometricians, a research assistant, two nurse coordinators for drug trials, and an administrative/regulatory assistant.
Training Opportunities
Research Opportunities
If you are interested in conducting research in cognitive neurology and/or dementia or are interested in assisting in ongoing research by our faculty, visit their bio pages for information on their specific research interests and how to get in touch.
For more information on current research initiatives in cognitive neurology, visit the Cognitive Neurology and Alzheimer Research Centre (CNARC) mini-site.
